guttitude logo

guttitude

early access
← Back to atlas
supportedmidmoderate inflation risk

Acinetobacter

atopic dermatitis

Acinetobacter is an interesting but still moderate-confidence signal in atopic dermatitis.

Acinetobacter shows a moderate evidence base in atopic dermatitis, with multiple central papers and additional supporting literature.

acinetobacter
Credibility score
18
Human translation
4/5
Reproducibility
2/5
Novelty
4/5
Actionability
2/5
Credibility 18Human translation 4/5Reproducibility 2/5Novelty 4/5Actionability 2/5
Why this scores the way it does
  • moderate central evidence base
Main caveats
  • directionality and confounding still require curated review

Primary central evidence

6 papers
Pattern of bacterial colonization of atopic dermatitis in saudi children.
2013
Journal of clinical and diagnostic research : JCDR
Direct disease-relevant human paper with strong clinical, biomarker, or mechanistic framing.
In vitro antimicrobial effects of a novel Pentaherbs concoction for atopic dermatitis.
2018
The Journal of dermatological treatment
Direct disease-relevant human paper with strong clinical, biomarker, or mechanistic framing.
Diagnostic Models for Atopic Dermatitis Based on Serum Microbial Extracellular Vesicle Metagenomic Analysis: A Pilot Study.
2020
Allergy, asthma & immunology research
Direct disease-relevant human paper with strong clinical, biomarker, or mechanistic framing.
Mother's Milk Microbiome Shaping Fecal and Skin Microbiota in Infants with Food Allergy and Atopic Dermatitis: A Pilot Analysis.
2021
Nutrients
Direct disease-relevant human paper with strong clinical, biomarker, or mechanistic framing.
Pharyngeal Microbiome in Atopic Dermatitis: A 16S rRNA Sequencing Study.
2025
Experimental dermatology
Direct disease-relevant human paper with strong clinical, biomarker, or mechanistic framing.
Washed microbiota transplantation relieves atopic dermatitis via gut-skin microbiome rebalancing.
2026
BMC microbiology
Direct disease-relevant human paper with strong clinical, biomarker, or mechanistic framing.

Supporting primary evidence

1 papers
Associations between early-life exposures and the infant skin microbiome.
2026
The British journal of dermatology
Human primary paper with plausible association relevance to the disease context.

Preclinical supporting evidence

2 papers
Topical ozone therapy restores microbiome diversity in atopic dermatitis.
2020
International immunopharmacology
Disease-relevant preclinical or model-based paper useful as supporting evidence.
A Pilot Study: Composition and Diversity of 16S rRNA Based Skin Bacterial Microbiome in Indonesian Atopic Dermatitis Population.
2021
Clinical, cosmetic and investigational dermatology
Disease-relevant preclinical or model-based paper useful as supporting evidence.